A Study to Assess the Safety, Tolerability and Efficacy of IONIS-AGT-LRx
Status:
Completed
Trial end date:
2020-07-20
Target enrollment:
Participant gender:
Summary
This study will evaluate the effect of IONIS-AGT-LRx on plasma angiotensinogen (AGT) and
systolic blood pressure (SBP) in uncontrolled hypertensive participants who are on two to
three antihypertensive medications.